Porton Pharma Solutions (SZSE:300363) Debt-to-Asset : 0.22 (As of Jun. 2024)

Porton Pharma Solutions Debt-to-Asset Chart

Porton Pharma Solutions Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Asset		Get a 7-Day Free Trial					0.09	0.11	0.11	0.09	0.21

Porton Pharma Solutions Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															0.14	0.15	0.21	0.21	0.22

Competitive Comparison of Porton Pharma Solutions's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Porton Pharma Solutions's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's Debt-to-Asset falls into.

Porton Pharma Solutions Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Porton Pharma Solutions's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Porton Pharma Solutions's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Porton Pharma Solutions  (SZSE:300363) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Porton Pharma Solutions Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Porton Pharma Solutions Business Description